JP2007520508A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007520508A5 JP2007520508A5 JP2006551763A JP2006551763A JP2007520508A5 JP 2007520508 A5 JP2007520508 A5 JP 2007520508A5 JP 2006551763 A JP2006551763 A JP 2006551763A JP 2006551763 A JP2006551763 A JP 2006551763A JP 2007520508 A5 JP2007520508 A5 JP 2007520508A5
- Authority
- JP
- Japan
- Prior art keywords
- physiologically acceptable
- acceptable salt
- glycopyrrolate
- glucocorticoid
- pharmaceutical product
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54195604P | 2004-02-06 | 2004-02-06 | |
| US60/541,956 | 2004-02-06 | ||
| PCT/EP2005/000652 WO2005074918A1 (en) | 2004-02-06 | 2005-01-24 | The combination of anticholinergics and glucocorticoids for the long-term treatment of asthma and copd |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2007520508A JP2007520508A (ja) | 2007-07-26 |
| JP2007520508A5 true JP2007520508A5 (enExample) | 2008-01-24 |
| JP4819699B2 JP4819699B2 (ja) | 2011-11-24 |
Family
ID=34837533
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006551763A Expired - Fee Related JP4819699B2 (ja) | 2004-02-06 | 2005-01-24 | 喘息及びｃｏｐｄの長期間の治療のための抗コリン作用薬及びグルココルチコイドの組合せ剤 |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20050175548A1 (enExample) |
| EP (1) | EP1713473B1 (enExample) |
| JP (1) | JP4819699B2 (enExample) |
| CN (1) | CN100569235C (enExample) |
| AU (1) | AU2005210085B2 (enExample) |
| CA (1) | CA2551780C (enExample) |
| DK (1) | DK1713473T3 (enExample) |
| ES (1) | ES2413011T3 (enExample) |
| HR (1) | HRP20130460T1 (enExample) |
| NO (1) | NO336882B1 (enExample) |
| NZ (1) | NZ548300A (enExample) |
| PL (1) | PL1713473T3 (enExample) |
| PT (1) | PT1713473E (enExample) |
| RU (1) | RU2440813C2 (enExample) |
| SI (1) | SI1713473T1 (enExample) |
| WO (1) | WO2005074918A1 (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| ES2257152B1 (es) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
| GB0523653D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523656D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523654D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523655D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| NZ568349A (en) * | 2005-12-21 | 2011-05-27 | Meda Pharma Gmbh & Co Kg | Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| WO2009142589A1 (en) * | 2008-05-20 | 2009-11-26 | Astrazeneca Ab | Combination of (a) glucocorticoid receptor modulator and (b) a muscarinic antagonist |
| TWI792140B (zh) * | 2009-05-29 | 2023-02-11 | 美商沛爾醫療股份有限公司 | 用於經由呼吸道遞送二或更多種活性藥劑的組成物、方法與系統 |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| CA2785321C (en) | 2009-12-23 | 2018-08-21 | Chiesi Farmaceutici S.P.A. | Combination therapy for copd |
| ES2468835T3 (es) | 2009-12-23 | 2014-06-17 | Chiesi Farmaceutici S.P.A. | Terapia combinada para EPOC |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| AU2013300009B2 (en) * | 2012-08-09 | 2017-06-15 | Chase Pharmaceuticals Corporation | Piperidinium quaternary salts |
| US8558008B2 (en) | 2013-02-28 | 2013-10-15 | Dermira, Inc. | Crystalline glycopyrrolate tosylate |
| JP6114841B2 (ja) | 2013-02-28 | 2017-04-12 | ダーミラ， インク．Ｄｅｒｍｉｒａ， Ｉｎｃ． | グリコピロレート塩 |
| US9006462B2 (en) | 2013-02-28 | 2015-04-14 | Dermira, Inc. | Glycopyrrolate salts |
| SG11201507286QA (en) | 2013-03-15 | 2015-10-29 | Pearl Therapeutics Inc | Methods and systems for conditioning of particulate crystalline materials |
| SI3089735T1 (sl) | 2013-12-30 | 2018-10-30 | Chiesi Farmaceutici S.P.A. | Sestavek stabilne aerosolne raztopine pod tlakom, ki vsebuje glikopironijev bromid in formoterol |
| EP4591936A3 (en) | 2015-03-23 | 2025-10-15 | Tianli Biotech Pty Ltd | Treatment of respiratory diseases |
| WO2016170518A1 (en) | 2015-04-24 | 2016-10-27 | Glenmark Specialty S.A. | Pharmaceutical compositions comprising arformoterol and glycopyrronium |
| US10098837B2 (en) | 2016-07-28 | 2018-10-16 | Chiesi Farmaceutici S.P.A. | Combination therapy for COPD |
| PE20191043A1 (es) | 2016-09-19 | 2019-08-06 | Mexichem Fluor Sa De Cv | Composicion farmaceutica |
| RU2691110C2 (ru) * | 2017-11-20 | 2019-06-11 | Федеральное государственное бюджетное учреждение науки Сибирский федеральный научный центр агробиотехнологий Российской академии наук (СФНЦА РАН) | Препарат для лечения заболеваний дыхательных путей у лошадей и способ его применения |
| WO2020093098A1 (en) | 2018-11-07 | 2020-05-14 | The University Of Melbourne | Novel compounds for the treatment of respiratory diseases |
| CN109498625B (zh) * | 2018-12-29 | 2021-04-16 | 温州医科大学附属第一医院 | 一种治疗慢性阻塞性肺疾病的药物组合物及其制备方法 |
| CN114502146A (zh) | 2019-12-02 | 2022-05-13 | 奇斯药制品公司 | 用于加压定量吸入器的不锈钢罐 |
| CN120360953B (zh) * | 2025-06-24 | 2025-09-05 | 成都第一制药有限公司 | 一种用于copd治疗的莨菪烷类生物碱组合物及其应用 |
Family Cites Families (37)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100331255B1 (ko) | 1993-07-02 | 2002-10-25 | 빅굴덴 롬베르그 케미쉐 화부리크 게엠베하 | 플루오로알콕시-치환된벤즈아미드및시클릭뉴클레오티드포스포디에스테라아제억제제로서의그의용도 |
| EP0932401A1 (en) * | 1996-07-01 | 1999-08-04 | Sepracor, Inc. | Methods and compositions for treating urinary incontinence using enantiomerically enriched (r,r)-glycopyrrolate |
| US6384038B1 (en) | 1998-04-14 | 2002-05-07 | Sepracor Inc. | Methods and compositions using cetirizine in combination with leukotriene inhibitors or decongestants |
| WO1999062720A1 (fr) | 1998-05-29 | 1999-12-09 | Citizen Watch Co., Ltd. | Procede permettant de soumettre une imprimante a jet d'encre a un traitement de pre-utilisation |
| EP1102579B1 (de) * | 1998-08-04 | 2003-03-19 | Jago Research Ag | Medizinische aerosolformulierungen |
| DK1131059T3 (da) * | 1998-11-13 | 2003-06-30 | Jago Res Ag | Tørpulver til inhalation |
| DE19921693A1 (de) | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
| US6086914A (en) | 1999-03-12 | 2000-07-11 | Weinstein; Robert E. | Nonsedating formulations for allergic rhinitis which possess antihistaminic and anticholinergic activity |
| US6203779B1 (en) * | 1999-03-19 | 2001-03-20 | Charlie Ricci | Methods for treating endoleaks during endovascular repair of abdominal aortic aneurysms |
| US20040002548A1 (en) | 1999-05-12 | 2004-01-01 | Boehringer Ingelheim Pharma Kg | Medicament compositions containing anticholinergically-effective compounds and betamimetics |
| DE19961300A1 (de) | 1999-12-18 | 2001-06-21 | Asta Medica Ag | Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator |
| DE10007203A1 (de) | 2000-02-17 | 2001-08-23 | Asta Medica Ag | Neue Kombination nichtsedierender Antihistaminika mit Substanzen, die die Leukotrienwirkung beeinflussen, zur Behandlung der Rhinitis/Konjunktivitis |
| GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
| GB0009583D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory formulations |
| GB0009584D0 (en) | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Pharmaceutical compositions |
| DE10110772A1 (de) | 2001-03-07 | 2002-09-12 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und PDE-IV-Inhibitoren |
| DE10062712A1 (de) | 2000-12-15 | 2002-06-20 | Boehringer Ingelheim Pharma | Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Corticosteroiden |
| GB0029903D0 (en) * | 2000-12-07 | 2001-01-24 | Arakis Ltd | Use of anti-muscarinic agents |
| DE50211045D1 (de) * | 2001-03-30 | 2007-11-22 | Jagotec Ag | Medizinische aerosolformulierungen |
| US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
| MXPA03010791A (es) | 2001-05-25 | 2004-03-02 | Boehringer Ingelheim Pharma | Combinacion de inhibidor de pde4 y tiotropio a sus derivados para tratamiento de enfermedades obstructivas de vias respiratorias y de otras enfermedades inflamatorias. |
| CZ20033150A3 (cs) | 2001-05-25 | 2004-06-16 | Pfizer Inc. | Inhibitor PDE4 a anticholinergní činidlo v kombinaci pro léčbu obstruktivních chorob dýchacích cest |
| GB0118373D0 (en) | 2001-07-27 | 2001-09-19 | Glaxo Group Ltd | Novel therapeutic method |
| CN1422620A (zh) * | 2001-12-07 | 2003-06-11 | 中国人民解放军总装备部后勤部军事医学研究所 | 治疗氮氧化物中毒的气雾剂及其用途和制备方法 |
| US7258118B2 (en) * | 2002-01-24 | 2007-08-21 | Sofotec Gmbh & Co, Kg | Pharmaceutical powder cartridge, and inhaler equipped with same |
| EP1487411B1 (en) * | 2002-03-20 | 2019-01-02 | Civitas Therapeutics, Inc. | Inhalable sustained therapeutic formulations |
| US7084153B2 (en) * | 2002-04-12 | 2006-08-01 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Medicaments comprising steroids and a novel anticholinergic |
| DE10216429A1 (de) * | 2002-04-12 | 2003-10-23 | Boehringer Ingelheim Pharma | Arzneimittel enthaltend Steroide und ein neues Anticholinergikum |
| US20040038958A1 (en) | 2002-07-11 | 2004-02-26 | Chris Rundfeldt | Topical treatment of skin diseases |
| UA82323C2 (uk) | 2002-08-09 | 2008-04-10 | Меда Фарма Гмбх & Ко. Кг | Нова комбінація глюкокортикоїду та pde-інгібітору для лікування респіраторних захворювань, алергічних захворювань, астми та хронічних обструктивних легеневих захворювань |
| WO2004023984A2 (en) | 2002-09-13 | 2004-03-25 | Smith C Steven | Novel composition and method for treatment of upper respiratory conditions |
| SI1610787T1 (sl) | 2003-03-28 | 2008-06-30 | Nycomed Gmbh | Sinergistična kombinacija, ki obsega roflumilastin antiholinergično sredstvo, izbrano izmed tiotropijevih soli, za zdravljenje respiratornih bolezni |
| US20060189642A1 (en) | 2003-03-28 | 2006-08-24 | Altana Pharma Ag | Synergistic combination comprising roflumilast and an anticholinergic agent selected from ipratropium, oxitropium and tiotropium salts for the treatment of respiratory diseases |
| JP2007530917A (ja) * | 2003-07-11 | 2007-11-01 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | 改善された周波数決定 |
| DE602005007708D1 (de) | 2004-02-06 | 2008-08-07 | Meda Pharma Gmbh & Co Kg | Neue kombination von anticholinergen und beta mimetika zur behanldung von atemwegserkrankungen |
| EP1720577A2 (en) | 2004-02-27 | 2006-11-15 | Altana Pharma AG | Ciclesonide and glycopyrronium combination |
| NZ568349A (en) | 2005-12-21 | 2011-05-27 | Meda Pharma Gmbh & Co Kg | Combination of anticholinergics, glucocorticoids, beta2-agonists, PDE 4 inhibitor and antileukotriene for the treatment of inflammatory diseases |
-
2005
- 2005-01-24 PT PT57069791T patent/PT1713473E/pt unknown
- 2005-01-24 HR HRP20130460TT patent/HRP20130460T1/hr unknown
- 2005-01-24 CN CNB200580004060XA patent/CN100569235C/zh not_active Expired - Fee Related
- 2005-01-24 WO PCT/EP2005/000652 patent/WO2005074918A1/en not_active Ceased
- 2005-01-24 CA CA2551780A patent/CA2551780C/en not_active Expired - Fee Related
- 2005-01-24 JP JP2006551763A patent/JP4819699B2/ja not_active Expired - Fee Related
- 2005-01-24 EP EP05706979A patent/EP1713473B1/en not_active Expired - Lifetime
- 2005-01-24 DK DK05706979.1T patent/DK1713473T3/da active
- 2005-01-24 SI SI200531713T patent/SI1713473T1/sl unknown
- 2005-01-24 RU RU2006132038/15A patent/RU2440813C2/ru not_active Application Discontinuation
- 2005-01-24 AU AU2005210085A patent/AU2005210085B2/en not_active Ceased
- 2005-01-24 PL PL05706979T patent/PL1713473T3/pl unknown
- 2005-01-24 ES ES05706979T patent/ES2413011T3/es not_active Expired - Lifetime
- 2005-01-24 NZ NZ548300A patent/NZ548300A/en not_active IP Right Cessation
- 2005-02-07 US US11/051,468 patent/US20050175548A1/en not_active Abandoned
-
2006
- 2006-08-31 NO NO20063879A patent/NO336882B1/no not_active IP Right Cessation
-
2008
- 2008-08-11 US US12/189,598 patent/US10537550B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007520508A5 (enExample) | ||
| RU2006132038A (ru) | Комбинация (варианты) и фармацевтический препарат для лечения заболеваний дыхательных путей | |
| CA2550841A1 (en) | Novel combination of anticholinergic and .beta. mimetics for the treatment of respiratory diseases | |
| JP2018199684A5 (enExample) | ||
| CA2496699A1 (en) | Pharmaceutical products and compositions comprising specific anticholinergic agents, beta-2 agonists and corticosteroids | |
| RU2008129600A (ru) | Комбинация и фармацевтический препарат для лечения воспалительных заболеваний | |
| JP2004514739A5 (enExample) | ||
| JP2013531056A5 (enExample) | ||
| JP2015519356A5 (enExample) | ||
| PT2506844T (pt) | Combinações de um antagonista do recetor muscarínico e um agonista do adrenorrecetor beta-2 | |
| JP2007520507A5 (enExample) | ||
| JP2019528316A5 (enExample) | ||
| JP2020023536A (ja) | Ｃｏｐｄの治療のためのフォルモテロール及びブデソニドの組み合わせ | |
| JP2008533072A5 (enExample) | ||
| US20140342001A1 (en) | Medicaments | |
| HUE031442T2 (en) | Aclidinium for use in improving the quality of sleep in respiratory patients. | |
| HRP20140818T1 (hr) | Farmaceutske aerosolne formulacije formoterola i beklometazon-dipropionata | |
| JP2007518817A5 (enExample) | ||
| JP2011500731A5 (enExample) | ||
| JP2019519572A5 (enExample) | ||
| JP2021191777A (ja) | 結晶多形および医薬組成物 | |
| WO2007046113A3 (en) | Novel pharmaceutical composition comprising alkaloid and process thereof | |
| Masekela et al. | Asthma treatment in children: A pragmatic approach | |
| Brand et al. | Drug delivery in pediatric patients with asthma: spacer devices vs nebulizers for β2 agonists | |
| Lyseng-Williamson | Formoterol/budesonide pressurized metered-dose inhaler: a guide to its use in chronic obstructive pulmonary disease |